Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Colfax, Investors, Johnson & Johnson, Merck: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading on Sept. 12. Stock symbols are in parentheses.

Colfax Corp. (CFX US): Charter International Plc is close to accepting a bid from the Fulton, Maryland-based manufacturer of pumps and specialty valves, the Daily Telegraph reported, citing unnamed sources.

Investors Real Estate Trust (IRET US): The Minot, North Dakota-based real estate investment trust reported funds from operations in the first quarter were 16 cents a share, matching the average analyst estimate.

Johnson & Johnson (JNJ US): The world’s second-biggest maker of health-care products failed to win U.S. clearance for wider use of Simponi, a two-year-old arthritis drug.

Merck & Co. (MRK US): The second-largest U.S. drugmaker, Warner Chilcott Plc, Roche Holding AG and Novartis AG should add clarifications on the length of time that osteoporosis patients may take their bone drugs to reduce the risk of fractures, outside advisers to the Food and Drug Administration said.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.